GlassScriptPhysician profile
Rohit Chopra
NPI 1023179363
$3,708.90
in general payments reported to CMS, 2019-2025
13 companies · $803 in 2025
The $803 reported for 2025 was more than what 87% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $352 · 2020: $137 · 2021: $44.41 · 2022: $1,337 · 2023: $747 · 2024: $289 · 2025: $803.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,655 · Travel and Lodging: $184.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,655.34 |
| Travel and Lodging | $184.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopervision INC. | $1,337.31 | 2020-2025 | Cvi Contact Lens, Myday Contact Lens |
| Glaukos Corporation | $597.47 | 2022-2025 | Photrexa Viscous and Photrexa |
| Alcon Vision LLC | $578.67 | 2019-2025 | Total30, Simbrinza, Rocklatan |
| Johnson & Johnson Vision Care, INC. | $206.84 | 2023-2025 | Acuvue |
| Tarsus Pharmaceuticals, INC. | $154.46 | 2025 | Xdemvy |
| Bausch & Lomb Americas INC. | $140.93 | 2024-2025 | Infuse |
| Sight Sciences, INC. | $131.25 | 2022 | |
| Novartis Pharmaceuticals Corporation | $125.65 | 2019 | |
| Horizon Therapeutics Plc | $125.00 | 2022 | |
| Apellis Pharmaceuticals, INC. | $124.99 | 2025 | Syfovre |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $124.55 | 2019 | |
| Abbott Laboratories | $44.41 | 2021 | |
| Catheter Precision, INC. Fka Ra Medical Systems, INC. | $17.37 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rohit Chopra listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.